Antipsychotic Efficacy and Safety of LB-102 in the Treatment of Adults With Acute Schizophrenia

Journal:

JAMA Psychiatry

Published:

2026-04-23

DOI:

10.1001/jamapsychiatry.2026.0428

Affiliations:

8

Authors:

10

Go to article

Institutions	Authors	Share
LB Pharmaceuticals, United States of America (USA)	5.000000	0.50
Segal Trials, United States of America (USA)	1.000000	0.10
Collaborative Neuroscience Research (CNS), United States of America (USA)	1.000000	0.10
Worldwide Clinical Trials - UK, United Kingdom (UK)	1.000000	0.10
Northwell Health, United States of America (USA)	0.750000	0.08
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, United States of America (USA)	0.750000	0.08
DZPG partner site Berlin-Potsdam, Germany	0.250000	0.03
Charité - University Medicine Berlin, Germany	0.250000	0.03

Interested in Clinical Sciences?